Chongyu Tian
Overview
Explore the profile of Chongyu Tian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Z, Tian C, Zhu J, Wang S, Ao X, He Y, et al.
J Nanobiotechnology
. 2025 Jan;
23(1):55.
PMID: 39881325
Background: The rapid mutation of avian influenza virus (AIV) poses a significant threat to both the poultry industry and public health. Herein, we have successfully developed an mRNA-LNPs candidate vaccine...
2.
Zhang Y, Tian C, Yu X, Yu G, Han X, Wang Y, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39771977
: The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a highly pathogenic virus causing severe respiratory illness, with limited treatment options that are mostly supportive. The success of mRNA technology...
3.
Peng W, Tai W, Li B, Wang H, Wang T, Guo S, et al.
Nat Mater
. 2024 Nov;
PMID: 39592721
Pneumonia is a ubiquitous disease caused by viral and bacterial infections, characterized by high levels of reactive oxygen species in inflamed areas. Therapeutic strategies targeting reactive oxygen species levels in...
4.
Yu H, Sun F, Xu Y, Yang H, Tian C, Li C, et al.
Hum Gene Ther
. 2024 Feb;
35(5-6):177-191.
PMID: 38386514
Oncolytic viruses (OVs) are appealing anti-tumor agents. But it is limited in its effectiveness. In this study, we used combination therapy with immune checkpoint inhibitor to enhance the antitumor efficacy...
5.
Tai W, Yang K, Liu Y, Li R, Feng S, Chai B, et al.
Nat Commun
. 2023 Dec;
14(1):8042.
PMID: 38052844
The respiratory system, especially the lung, is the key site of pathological injury induced by SARS-CoV-2 infection. Given the low feasibility of targeted delivery of antibodies into the lungs by...
6.
Sun F, Lei G, Tian C, Bai Z, Bai C, Li Y, et al.
Virulence
. 2023 Nov;
:2284515.
PMID: 37974334
Human metapneumovirus (HMPV) is a leading cause of acute respiratory tract infections in infants and children. Currently, no approved HMPV vaccine is available. We developed a novel recombinant influenza virus,...
7.
Li C, Tian Y, Sun F, Lei G, Cheng J, Tian C, et al.
Hum Gene Ther
. 2023 Aug;
35(1-2):48-58.
PMID: 37646399
Oncolytic viruses are able to lyse tumor cells selectively in the liver without killing normal hepatocytes, in addition to activating the immune response. Oncolytic virus therapy is expected to revolutionize...
8.
Shi B, Han H, Li H, Tan L, Li X, Wang K, et al.
J Pers Med
. 2022 Dec;
12(12).
PMID: 36556283
(1) Background: With the resurgence of brucellosis epidemics in China in recent years, the chances of a brucella coinfection with other common respiratory pathogens, such as the influenza virus, have...